Literature DB >> 16355671

Renal biopsy: a retrospective study of methods and complications in 283 dogs and 65 cats.

Shelly L Vaden1, Jay F Levine, George E Lees, Reid P Groman, Gregory F Grauer, S Dru Forrester.   

Abstract

Renal biopsy often is required to establish a definitive diagnosis in dogs and cats with renal disease. In this retrospective study, we determined the complications of renal biopsy as well as factors that may be associated with development of complications and procurement of adequate renal biopsy specimens in 283 dogs and 65 cats. Data extracted from medical records at 4 institutions were evaluated using logistic regression. Proteinuria was the most common indication for renal biopsy in dogs. Complications were reported in 13.4 and 18.5% of dogs and cats, respectively. The most common complication was severe hemorrhage; hydronephrosis and death were uncommon. Dogs that developed complications after renal biopsy were more likely to have been 4 to < 7 years of age and > 9 years, to weigh < or = 5 kg, and to have serum creatinine concentrations > 5 mg/dL. The majority of biopsies from both dogs (87.6%) and cats (86.2%) were considered to be of satisfactory quality. Biopsies from dogs were more likely to be of high quality if they were obtained when the patient was under general anesthesia and more likely to contain only renal cortex if they were obtained by surgery. We concluded that renal biopsy is a relatively safe procedure, with a low frequency of severe complications. Hospital practices and patient variables have the potential to impact both the quality of the specimen obtained and the rate of complications.

Entities:  

Mesh:

Year:  2005        PMID: 16355671     DOI: 10.1892/0891-6640(2005)19[794:rbarso]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  7 in total

1.  Histopathological retrospective study of canine renal disease in Korea, 2003~2008.

Authors:  Ji-Young Yhee; Chi-Ho Yu; Jong-Hyuk Kim; Keum-Soon Im; Seung-Ki Chon; Jung-Hyang Sur
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

Review 2.  Proteinuria in dogs and cats.

Authors:  Leyenda Harley; Cathy Langston
Journal:  Can Vet J       Date:  2012-06       Impact factor: 1.008

3.  Weight-gain induced changes in renal perfusion assessed by contrast-enhanced ultrasound precede increases in urinary protein excretion suggestive of glomerular and tubular injury and normalize after weight-loss in dogs.

Authors:  Daisy J X Liu; Emmelie Stock; Bart J G Broeckx; Sylvie Daminet; Evelyne Meyer; Joris R Delanghe; Siska Croubels; Mathias Devreese; Patrick Nguyen; Evelien Bogaerts; Myriam Hesta; Katrien Vanderperren
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

4.  Contrast-enhanced computed tomography findings of canine primary renal tumors including renal cell carcinoma, lymphoma, and hemangiosarcoma.

Authors:  Toshiyuki Tanaka; Hideo Akiyoshi; Hidetaka Nishida; Keiichiro Mie; Lee-Shuan Lin; Yasumasa Iimori; Mari Okamoto
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

5.  Variation in biochemistry test results between annual wellness visits in apparently healthy Golden Retrievers.

Authors:  Unity Jeffery; Nick D Jeffery; Kate E Creevy; Rod Page; Melissa J Simpson
Journal:  J Vet Intern Med       Date:  2021-02-02       Impact factor: 3.333

6.  Early Renal Involvement in Cats with Natural Feline Morbillivirus Infection.

Authors:  Paolo Emidio Crisi; Francesco Dondi; Eliana De Luca; Morena Di Tommaso; Kateryna Vasylyeva; Enea Ferlizza; Giovanni Savini; Alessia Luciani; Daniela Malatesta; Alessio Lorusso; Andrea Boari
Journal:  Animals (Basel)       Date:  2020-05-10       Impact factor: 2.752

7.  Glomerulotubular pathology in dogs with subclinical ehrlichiosis.

Authors:  Leandro Zuccolotto Crivellenti; Cristiane Alves Cintra; Suellen Rodrigues Maia; Gyl Eanes Barros Silva; Sofia Borin-Crivellenti; Rachel Cianciolo; Christopher A Adin; Mirela Tinucci-Costa; Caio Santos Pennacchi; Aureo Evangelista Santana
Journal:  PLoS One       Date:  2021-12-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.